[Advantage of the diuretic "thiazide-spironolactone" associati in the treatment of arterial hypertension].
D001581:Benzothiadiazines / Q000008:administration & dosage* / Q000009:adverse effects; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D003404:Creatinine; D004357:Drug Synergism; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008657:Metabolic Clearance Rate; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000008:administration & dosage* / Q000009:adverse effects; D014527:Uric Acid / Q000097:blood
D001581:Benzothiadiazines; D001786:Blood Glucose; D014527:Uric Acid; D013148:Spironolactone; D012964:Sodium; D003404:Creatinine; D011188:Potassium
Intérêt d'une association diurétique "thiazide spironolactone" dans le traitement de l'hypertension artérielle.